Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
3(18%)
Results Posted
33%(2 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_2
6
35%
Ph phase_3
3
18%
Ph phase_1
1
6%
Ph not_applicable
5
29%

Phase Distribution

1

Early Stage

6

Mid Stage

3

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
1(6.7%)
Phase 2Efficacy & side effects
6(40.0%)
Phase 3Large-scale testing
3(20.0%)
N/ANon-phased studies
5(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(6)
Completed(6)
Terminated(4)
Other(1)

Detailed Status

Completed6
Withdrawn3
Not yet recruiting3
Recruiting2
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
85.7%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (6.7%)
Phase 26 (40.0%)
Phase 33 (20.0%)
N/A5 (33.3%)

Trials by Status

recruiting212%
unknown16%
withdrawn318%
completed635%
not_yet_recruiting318%
active_not_recruiting16%
terminated16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT06807359Phase 1

Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System

Recruiting
NCT07241585Not Applicable

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Not Yet Recruiting
NCT05923060Phase 2

Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses

Completed
NCT02662504Phase 2

Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma

Completed
NCT06777511

Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients

Not Yet Recruiting
NCT07376824Phase 3

Clinical and Metabolomics Studies on the Improvement of Ovarian Reserve by Acupoint Photodynamic Therapy and Traditional Chinese Medicine Treatment

Recruiting
NCT07266233Not Applicable

Toluidine Blue-Based Photodynamic Therapy for Antibacterial Activity and Postoperative Pain

Active Not Recruiting
NCT06939400

Photodynamic Therapy for Glioblastoma Multiforme Based on Metaverse and Yellow Fluorescence

Not Yet Recruiting
NCT00472108Phase 3

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

Completed
NCT04140292Phase 2

Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses

Completed
NCT00756288Not Applicable

Photo-therapy With a Topical Retinoid Versus Photo-therapy Alone for Actinic Keratoses

Withdrawn
NCT03346304Phase 2

Photodynamic Therapy for the Prevention of Lung Cancer

Withdrawn
NCT02004600Not Applicable

Pilot Study Evaluating the Efficiency and the Tolerance of the PDT in the Treatment of Epidermal Dysplasia for Patients Affected by Hereditary DEB

Withdrawn
NCT00041483Phase 3

Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD

Completed
NCT01739465Phase 2

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

Unknown
NCT00984243Not Applicable

Photodynamic Therapy (PDT) in Lung Cancer

Completed
NCT00464347Phase 2

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration

Terminated

All 17 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
17